Insiders Orexo AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 11:29:49 2024-04-26 am EDT			5-day change	1st Jan Change
16.54 ^SEK	-2.71%		+0.12%	+6.99%

Apr. 17	Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment	MT
Apr. 17	Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US	CI

Orexo AB Announces Board Resignations	Mar. 22	CI
Orexo AB Announces Changes in the Board of Directors	23-10-27	CI
Orexo AB Announces Nomination Committee Appointments	23-10-26	CI
Orexo AB Announces Resignation of Robin Evers as A Board Member	23-10-26	CI
Orexo AB Announces Henrik Kjær Hansen Will Resign from the Board of Directors	23-10-02	CI
Orexo Hires New Chief Medical Officer	22-10-26	MT
Orexo AB Appoints Edward Kim, M.D., as New Chief Medical Officer	22-10-26	CI
Orexo's Nomination Committee for the Annual General Meeting 2023	22-10-17	AQ
Orexo AB Announces Board Appointments	22-04-21	CI
Swedish Pharma Firm Orexo Names New CFO	22-03-11	MT
Orexo AB Announces Executive Changes	22-03-11	CI
Orexo's Nomination Committee for the Annual General Meeting 2022	21-11-01	AQ
Orexo AB Appoints Nomination Committee	21-11-01	CI
Orexo AB Announces Management Changes	20-10-13	CI
Orexo : Nomination Committee for the Annual General Meeting 2021	20-10-13	AQ
Orexo publ : James Noble appointed as Chairman of the Board	20-04-16	AQ
Orexo AB Announces Board Changes	20-04-16	CI
Orexo AB Appoints Dennis Urbaniak as Executive Vice President Digital Health	19-12-02	CI
Orexo publ : ´s Nomination Committee for the Annual General Meeting 2020	19-10-14	PU
Orexo AB Announces Nomination Committee Appointments	19-10-14	CI

No results for this search